Genelux GNLX
NASDAQ GNLX
$2.02 -0.05 (-2.66%)
As of: Oct 22, 2026 · 2:29 PM EDT

Genelux (GNLX) Other non-cash items (2023 - 2026)

Updated

Analysis

Genelux (GNLX) Other non-cash items (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.12 Bn 1,135.70 Bn 19.71 Bn
2 Johnson & Johnson 647.48 Bn 567.35 Bn 17.30 Bn
3 AbbVie 502.73 Bn 475.84 Bn 12.70 Bn
4 Merck 363.86 Bn 318.23 Bn 12.21 Bn
5 Novartis Ag 303.31 Bn 267.30 Bn 11.24 Bn
6 Astrazeneca 269.08 Bn 242.77 Bn 12.86 Bn
7 Amgen 242.07 Bn 197.46 Bn 7.24 Bn
8 Gilead Sciences 194.93 Bn 169.12 Bn 6.22 Bn
9 Pfizer 172.42 Bn 119.07 Bn 10.94 Bn
10 Genelux 88.96 Mn 27.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 408,000.00
Dec 31, 2025 94,000.00
Sep 30, 2025 290,000.00
Jun 30, 2025 105,000.00
Mar 31, 2025 183,000.00
Dec 31, 2024 -435,000.00
Sep 30, 2024 227,000.00
Jun 30, 2024 136,000.00
Mar 31, 2024 989,000.00
Dec 31, 2023 -236,000.00
Sep 30, 2023 147,000.00
Jun 30, 2023 402,000.00
Mar 31, 2023 198,000.00
API Access

Genelux Other non-cash items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-cash-items&ticker=GNLX&period=max&api_key=YOUR_API_KEY